MedTrace Logo

Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia

NCT05174845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13393

Last updated 2022-05-31

No results posted yet for this study

Summary

A retrospective study to evaluate the effectiveness and safety of 1L polyethylene glycol (PEG)+ Ascorbic acid given for bowel preparation before colonoscopy.

Conditions

Interventions

DRUG

1L PEG + ASCORBIC ACID

* 2-Day Split-Dosing: The patient has taken the product in the evening before the scheduled colonoscopy and mandatory additional clear fluid. The patient has taken the second dose with mandatory additional clear fluids on the morning of the colonoscopy. * Same Day: The patient has taken the first dose of the product on the day of the colonoscopy and take mandatory additional clear fluid. After a 1-2 hour break, the patient has taken a second dose plus additional clear mandatory fluid.

Sponsors & Collaborators

  • Xolomon Tree S.L.

    collaborator UNKNOWN

  • Norgine

    lead INDUSTRY

Principal Investigators

  • Jose Miguel Esteban López-Jamar, MD · Norgine Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-03-01
Completion
2022-03-01
FDA Drug
Yes

Countries

  • Portugal
  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05174845 on ClinicalTrials.gov